Nougarede, Adrien <br/><br/>
Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10.  [electronic resource] 

 -  Cancer research  03 2018 
 - 1404-1417 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-17-0846  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Binding Sites<br/>Biomarkers, Tumor--analysis<br/>Breast Neoplasms--drug therapy<br/>Calcium--metabolism<br/>Cell Line, Tumor<br/>Drug Resistance, Neoplasm<br/>Endoplasmic Reticulum--drug effects<br/>Female<br/>Humans<br/>Inositol 1,4,5-Trisphosphate Receptors--metabolism<br/>Mice, SCID<br/>Molecular Targeted Therapy--methods<br/>Peptide Fragments--metabolism<br/>Peptides--pharmacology<br/>Prognosis<br/>Proto-Oncogene Proteins--metabolism<br/>Proto-Oncogene Proteins c-bcl-2--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays